LOADING
Comparing Johnson & Johnson (JNJ) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | QCOM |
|---|---|---|
| Price | $270.24 | $160.75 |
| Change Today | +1.07% | +0.01% |
| Market Cap | $651.3B | $168.8B |
| P/E Ratio | 31.4 | 18.4 |
| Forward P/E | 23.2 | 15.8 |
| PEG Ratio | 4.73 | 0.71 |
| EPS | $8.62 | $8.74 |
| Revenue Growth (YoY) | 6.6% | -4.0% |
| Profit Margin | 21.5% | 21.0% |
| Return on Equity | 25.7% | 33.8% |
| Dividend Yield | 1.96% | 2.23% |
| Beta | 0.23 | 1.66 |
| 52-Week High | $276.47 | $258.96 |
| 52-Week Low | $170.33 | $121.54 |
| Volume | 6.2M | 8.5M |
Johnson & Johnson is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Qualcomm Inc offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.